Clinical trials: Mammographic Density
Case Control Study
Mammographic Density and the Risk of Tumor Recurrence in Asian Women: a Case-control Study
To evaluate the influence of mammographic breast density at diagnosis on the risk of cancer recurrence and survival outcome in patients with invasive breast cancer after surgery
- Trial name
- NCT02771665
- Testing
- Mammographic breast density at diagnosis
- Volunteers
- 300 people
- Sponsor
- National Taiwan University Hospital
Breast Cancer, Mammographic Breast Density
PERsonalized Mammographic Screening in Norway
The aim of this study is to assess attendance among women invited to additional breast imaging because they were identified as having an increased risk of breast cancer at screening.
- Conditions
- Breast Cancer, Mammographic Breast Density, Risk Stratification
- Trial name
- PERMS (NCT07371702)
- Volunteers
- 3,000 people, healthy volunteers welcome
- Sponsor
- Norwegian Institute of Public Health
Breast Cancer
Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density
It has been shown that women who have dense breasts have an increased risk of breast cancer compared with women whose breasts are less dense.
- Trial name
- NCT00418236
- Where
- 37 sites in United States, Argentina and 12 more
- Volunteers
- 400 people
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
Breast Cancer Prevention, Mammographic Density
RANKL Inhibition and Breast Tissue Biomarkers
A robust knowledge of how to reduce breast density could play a key role in breast cancer prevention in premenopausal women, but viable preventative targets to reduce breast density-associated breast cancer risk are yet to be…
- Trial name
- NCT03629717
- Testing
- Ultrasound-guided core needle biopsy, Denosumab, Blood draw
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Washington University School of Medicine